Search Results for: January

Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults – Increasing Community Access to Testing Program, United States, September 2023-January 2024.

Coronavirus Literature
Publication date: Feb 01, 2024 On September 12, 2023, CDC’s Advisory Committee on Immunization Practices recommended updated 2023-2024 (updated) COVID-19 vaccination with a monovalent XBB. 1.5-derived vaccine for all persons ... Read more